Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review

More articles from OR: Clinical Therapeutics/New Technology—Other Therapeutic Agents

  • You have access
    182-OR: A Novel Dual-Acting Glucokinase Activator (GKA) Dorzagliatin (HMS5552) Achieved Primary Efficacy Endpoint with Good Safety Profiles in T2DM Patients after 24 Weeks of Treatment in a Phase III Monotherapy Trial
    DALONG ZHU, YI ZHANG, LI CHEN
    Diabetes Jun 2020, 69 (Supplement 1) 182-OR; DOI: 10.2337/db20-182-OR
  • You have access
    183-OR: Allogenic Adipose-Derived Mesenchymal Stem Cells (ASCs) and Vitamin D Supplementation in Patients with Recent-Onset Type 1 Diabetes Mellitus: A 6-Month Follow-Up Pilot Study
    JOANA R. DANTAS, DEBORA B. ARAUJO, LEANDRA S. BAPTISTA, DEBORA L. SOUTO, KARINA PEREIRA, MARIA F. PEREIRA, CESAR S. CLAUDIO-DA-SILVA, MATHEUS S. MANTUANO, DEBORA R. DAGA, ALEXANDRA C. SENEGAGLIA, CARMEN K. REBELATTO, CARLOS EDUARDO B. COURI, JOSE E. OLIVEIRA, LENITA ZAJDENVERG, MELANIE RODACKI
    Diabetes Jun 2020, 69 (Supplement 1) 183-OR; DOI: 10.2337/db20-183-OR
  • You have access
    180-OR: Dasiglucagon as a Fast and Effective Treatment for Severe Hypoglycemia in Children with Diabetes
    TADEJ BATTELINO, RAMIN TEHRANCHI, ANITA E. MELGAARD, DORTE SKYDSGAARD, TIMOTHY S. BAILEY, LINDA DIMEGLIO, THOMAS DANNE
    Diabetes Jun 2020, 69 (Supplement 1) 180-OR; DOI: 10.2337/db20-180-OR
  • You have access
    181-OR: Effect of Sevelamer and a Synbiotic on Insulin Sensitivity in Obese Individuals
    ERIC BAEUERLE, HANYU LIANG, VINUTHA GANAPATHY, ROMAN FERNANDEZ, NATTAPOL SATHAVARODOM, CHEN-PIN WANG, SARA E. ESPINOZA, NICOLAS MUSI
    Diabetes Jun 2020, 69 (Supplement 1) 181-OR; DOI: 10.2337/db20-181-OR
  • You have access
    184-OR: Liver Fibrosis Scores Do Not Predict Response to Therapy in T2DM
    OLGA LAVRYNENKO, MARIAM ALATRACH, MUHAMMAD ABDUL-GHANI, EUGENIO CERSOSIMO, NAIM ALKHOURI, CURTISS L. PUCKETT, RALPH A. DEFRONZO, JOHN M. ADAMS, JUAN A. VASQUEZ, GEOFFREY D. CLARKE
    Diabetes Jun 2020, 69 (Supplement 1) 184-OR; DOI: 10.2337/db20-184-OR
  • You have access
    186-OR: Safety and Tolerability of the Next Generation Aldose Reductase Inhibitor (ARI) AT-001 Supports Initiation of the Pivotal Trial in Diabetic Cardiomyopathy (DbCM)
    RICCARDO PERFETTI, FRANCESCA C. LAWSON, JULIO ROSENSTOCK, JAMES JANUZZI, SHOSHANA SHENDELMAN, STELLA WANG, AMEEN F. GHANNAM
    Diabetes Jun 2020, 69 (Supplement 1) 186-OR; DOI: 10.2337/db20-186-OR
  • You have access
    179-OR: Mitochondrially Targeted Tamoxifen Improves Diet-Induced Obesity and Diabetes and Reduces Adipose Tissue Senescence in Experimental Mice
    JAROSLAVA TRNOVSKA, ELISKA DAVIDOVA, PETR SVOBODA, HELENA KRATOCHVILOVA, MILOS MRAZ, SONA HUBACKOVA, JIRI NEUZIL, MARTIN HALUZIK
    Diabetes Jun 2020, 69 (Supplement 1) 179-OR; DOI: 10.2337/db20-179-OR
  • You have access
    185-OR: Efficacy and Safety of Bempedoic Acid in Patients with Diabetes, Prediabetes, and Normoglycemia: Analysis of Pooled Patient-Level Data from Four Phase 3 Clinical Trials
    LAWRENCE A. LEITER, MACIEJ BANACH, ALBERICO L. CATAPANO, P. BARTON DUELL, ANTONIO GOTTO, ULRICH LAUFS, G.B. JOHN MANCINI, KAUSIK K. RAY, JEFFREY C. HANSELMAN, AMY FENG, HAROLD BAYS
    Diabetes Jun 2020, 69 (Supplement 1) 185-OR; DOI: 10.2337/db20-185-OR
  • You have access
    18-OR: Efficacy and Safety of Chiglitazar vs. Sitagliptin in Patients with Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Noninferiority Phase 3 Trial (CMAS)
    WEIPING JIA, JIANHUA MA, HENG MIAO, CHANGJIANG WANG, XIAOYUE WANG, QUANMIN LI, WEIPING LU, JIALIN YANG, LIHUI ZHANG, JINKUI YANG, GUIXIA WANG, XIUZHENG ZHANG, MIN ZHANG, LI SUN, XUEFENG YU, JIANLING DU, BINGYIN SHI, CHANGQING XIAO, DALONG ZHU, HONG LIU, LIYONG ZHONG, CHUN XU, QI XU, GANXIONG LIANG, YING ZHANG, GUANGWEI LI, MINGYU GU, JUN LIU, ZHIQIANG NING, LINONG JI
    Diabetes Jun 2019, 68 (Supplement 1) 18-OR; DOI: 10.2337/db19-18-OR
  • You have access
    20-OR: GPR142 Agonists Increase Glucose-Dependent Insulin Secretion and Differentially Regulate Hormone Secretion in Preclinical and Phase 1 Studies
    EDWARD J. PRATT, TOMONORI OURA, XIAOSU MA, HUA V. LIN, TIANWEI MA, ALEXANDER M. EFANOV, MELISSA K. THOMAS
    Diabetes Jun 2019, 68 (Supplement 1) 20-OR; DOI: 10.2337/db19-20-OR

Pages

  • Next
  • 1
  • 2

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.